Protection of hepatocytes from cyototoxic T cell mediated killing by interferon-alpha

PLoS ONE

Volumn 2, Issue 8, 2007, Pages

  Willberg, Christian B ^a,e   Ward, Scott M ^a,f   Clayton, Reginald F ^b   Naoumov, Nikolai V ^c   McCormick, Christopher ^d,g   Proto, Sandra ^c   Harris, Mark ^d   Patel, Arvind H ^b   Klenerman, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUTE OF VIROLOGY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f PRINCESS ALEXANDRA HOSPITAL   (Australia)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; PROTEINASE INHIBITOR; GRANZYME;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL KILLING; CELL LINE; CELL MEDIATED CYTOTOXICITY; CELL PROTECTION; CELL STRAIN HEPG2; CELLULAR IMMUNITY; CHRONICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER BIOPSY; LIVER CELL; PERSISTENT INFECTION; REPLICON; VIRUS GENOME; CYTOLOGY; CYTOTOXICITY; IMMUNOLOGY; METABOLISM;

HEPATITIS C VIRUS;

APOPTOSIS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; HEPATOCYTES; HUMANS; INTERFERON-ALPHA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 39549110054     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000791     Document Type: Article

References (40)

1. Hepatitis C-global prevalence (update). Wkly Epidemiol Rec 74: 425-427.
2. Lechner F, Cuero AL, Kantzanou M, Klenerman P (2001) Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers. Rev Med Virol 11: 11-22.
3. Lechner F, Gruener NH, Urbani S, Uggeri J, Santantonio T, et al. (2000) CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 30: 2479-2487.
4. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, et al. (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499-1512.
5. Calne RY (1969) "Strange english PIGS". Lancet 2: 940-941.
6. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, et al. (1969) Induction of immunological tolerance by porcine liver allografts. Nature 223: 472-476.
7. Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, et al. (2000) Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 6: 1348-1354.
8. Bertolino P, McCaughan GW, Bowen DG (2002) Role of primary intrahepatic T-cell activation in the 'liver tolerance effect'. Irrummol Cell Biol 80: 84-92.
9. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ (1984) The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 38: 287-292.
10. Eisenberger CF, Viebahn R, Lauchart W, de Groot H, Becker HD (1994) MHC antigen presentation on the surface of hepatocytes: modulation during and after hypoxic stress. Transpl Int 7 Suppl 1: S163-166.
11. Gugenheim J, Reynes M, Crafa F, Saint-Paul MC, Fabiani B, et al. (1996) Normothermic ischemia induces major histocompatibility complex class I expression in hepatocytes. Eur Surg Res 28: 256-261.
12. So SK, Plan JL, Ascher NL, Snover DC (1987) Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation 43: 79-85.
13. Lau JY, Bird GL, Naoumov NV, Williams R (1993) Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology. Dig Dis Sci 38: 888-895.
14. Guidotti LG, Borrow P, Brown A, McClary H, Koch R, et al. (1999) Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med 189: 1555-1564.
15. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, et al. (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825-829.
16. Clayton RF, Rinaldi A, Kandyba EE, Edward M, Willberg C, et al. (2005) Liver cell lines for the study of hepatocyte functions and immunological response. Liver Int 25: 389-402.
17. Bertoletti A, Costanzo A, Chisari FV, Levero M, Artini M, et al. (1994) Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180: 933-943.
18. Chisari FV (1997) Cytotoxic T cells and viral hepatitis. J Clin Invest 99: 1472-1477.
19. Timm Jr Lauer GM, Kavanagh DG, Sheridan I, Kim AY, et al. (2004) CD8 epitope escape and reversion in acute HCV infection. J Exp Med 200: 1593-1604.
20. Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23: 307-336.
21. Hermans IF, Silk JD, Yang J, Palmowski MJ, Gileadi U, et al. (2004) The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J Immunol Methods 285: 25-40.
22. Jensen ER, Glass AA, Clark WR, Wing EJ, Miller JF, et al. (1998) Fas (CD95)- dependent cell-mediated immunity to Listeria monocytogenes. Infect Immun 66: 4143-4150.
23. Kafrouni MI, Brown GR, Thiele DL (2001) Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanism. J Immunol 167: 1566-1574.
24. Li XK, Fujino M, Sugioka A, Morita M, Okuyama T, et al. (2001) Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers. Transplantation 71: 503-508.
25. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, et al. (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809.
26. Song E, Lee SK, Wang J, Ince N, Ouyang N, et al. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9: 347-351.
27. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326.
28. Balaji KN, Schaschke N, Machleidt W, Catalfarno M, Henkart PA (2002) Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med 196: 493-503.
29. Sun J, Bird CH, Sutton V, McDonald L, Coughlin PB, et al. (1996) A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J Biol Chem 271: 27802-27809.
30. Tsuzuki S, Kokado Y, Satomi S, Yamasaki Y, Hirayasu H, et al. (2003) Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A. Biochem J 372: 227-233.
31. Barrie MB, Stout HW, Abougergi MS, Miller BC, Thiele DL (2004) Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6. J Immunol 172: 6453-6459.
32. Uda K, Murata A, Nishijima J, Doi S, Tomita N, et al. (1994) Elevation of circulating monitor peptide/pancreatic secretory trypsin inhibitor-I (PSTI-61) after turpentine-induced inflammation in rats: hepatocytes produce it as an acute phase reactant. J Surg Res 57: 563-568.
33. McCormick CJ, Challinor L, Macdonald A, Rowlands DJ, Harris M (2004) Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system. J Gen Virol 85: 429-439.
34. McCormick CJ, Rowlands DJ, Harris M (2002) Efficient delivery and regulable expression of hepatitis C virus full-lenght and minigenome constructs in hepatocyte-derived cell lines using baculovirus. J Gen Virol 83: 383-394.
35. Jin Y, Fuller L, Carreno M, Zucker K, Roth D, et al. (1997) The immune reactivity role of HCV-induced liver infiltrating lymphocytes in hepatocellular damage. J Clin Immunol 17: 140-153.
36. Guidotti LG, McClary H, Loudis JM, Chisari FV (2000) Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med 191: 1247-1252.
37. Schofield L, Ferreira A, Altszuler R, Nussenzweig V, Nussenzweig RS (1987) Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J Immunol 139: 2020-2025.
38. Schultz U, Chisari FV (1999) Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J Virol 73: 3162-3168.
39. Ehl S, Klenerman P, Zinkernagel RM, Bocharov G (1998) The impact of variation in the number of CD8(+) T-cell precursors on the outcome of virus infection. Cell Immunol 189: 67-73.
40. Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF (2001) A novel technique for the fluorometric amessment of T lymphocyte antigen specific lysis. J Immunol Methods 249: 99-110.